GloPID-R is led by a Board of Chairs who are elected at the Assembly from amongst the members and hold office for 2 years (renewable for a maximum of two consecutive terms). They work in close cooperation with the Secretariat, a Scientific Advisor and committees based on the delegation from the Assembly.
The Chairs convene the Annual General Assembly, where members meet face-to-face, and the regular 3-monthly teleconferences. Meetings may also be called by the Chairs should an urgent epidemic alert arise.
The Chairs propose the meeting agendas, determine items for information and decision between the meetings and oversee the work of the Secretariat.
During the Assembly, decisions are taken about the GloPID-R work programme that the Chairs and the Secretariat have prepared and proposed.
The seventh Annual General Assembly for the GloPID-R members was held on May 13-14, 2019 at the Japan Agency for Medical Research and Development (AMED) in Tokyo, Japan.